IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
29 hedge funds and large institutions have $37.1M invested in Interpace Biosciences, Inc. Common Stock in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
-15
Holders Change %
-34.09%
% of All Funds
0.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
9
Reduced
11
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
RA
Royce & Associates
New York
|
-$1.09M |
| 2 |
KSC
Kendall Square Capital
San Francisco,
California
|
-$673K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$355K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$205K |
| 5 |
CI
Cowen Inc
New York
|
-$163K |
